Researchers hope that the study could lead to new osteoporosis treatments that tackle bone loss and address some of the wider metabolic consequences of menopause.

RNAV8 will be part of a team led by the Rouskin Lab at Harvard Medical School with the Weissman Lab at MIT/the Whitehead ...

A secured bioinformatics backbone, the most critical part of next-generation sequencing, means reliable, auditable data handling.

The funds will support efforts to advance its lead candidate into human clinical trials in 2027, and expand its pipeline of ...

BrainChild Bio has raised a $116 million Series A financing, the proceeds of which will, in part, fund the pivotal ...

Gene therapy will not reach its full potential as a transformative treatment for genetic diseases unless manufacturing ...

Medicines Discovery Catapult (MDC) says it is a life sciences service dedicated to turning drug discovery into commercial breakthroughs.

Experiments revealed the profound influence of microenvironmental context on uropathogenic E. coli infection dynamics and ...

Venetoclax, a cancer drug that inhibits BCL-2, reduced the intact SIV reservoir in macaques and may inform future HIV cure ...

The Boulder, CO, site is scheduled to become operational in the second half of 2027, following completion and qualification.

Results show that eliminating dendritic cells from the lymph nodes wiped out elevated levels of T cells in mice, and slowed cognitive decline.

Preclinical findings are the basis for an upcoming Phase II clinical trial evaluating psilocybin during chemotherapy in ...